Registration gives the benefit of site update e-mails and additional information from Shire on new education materials and events.
ADHD Institute Register

The 'Adult ADHD and comorbid anxiety disorders' webinar was hosted by Dr Mohamed Abdelghani (Dyad Medical, London, UK) on Monday 2 July. He was joined by a panel of experts from across the UK, Dr Joe Johnson, Dr Peter Mason and Dr Kuben Naidoo, for an interactive patient case study discussion.

These webinars may in part reflect the personal experiences and opinions of the presenters. Treatment-related statements do not necessarily reflect Shire’s position nor are they necessarily in line with the approved labels in all countries.


Question 1 (of 4)

In the Spanish CAT study, what percentage of adult patients with ADHD presented with one or more psychiatric comorbidity?

Please select one of the following

12.6%
35.5%
53.9%
66.2%

Question 2 (of 4)

What was the 12-month prevalence of any comorbid anxiety disorder in adults with ADHD in the US National Comorbidity Survey Replication?

Please select one of the following

13.6%
21.3%
35.4%
47.1%

Question 3 (of 4)

What was the 12-month prevalence of comorbid ADHD in adults with generalised anxiety disorder in the US National Comorbidity Survey Replication?

Please select one of the following

2.8%
11.9%
16.3%
21.2%

Question 4 (of 4)

In the Swedish population-based twin study by Friedrichs and colleagues (n=17,899; age 20–47 years), which ADHD subtype had the highest odds of comorbid generalised anxiety disorder?

Please mark all that apply

Combined type
Hyperactive-impulsive type
Inattentive type

Question 1 (of 4)

In the Spanish CAT study, what percentage of adult patients with ADHD presented with one or more psychiatric comorbidity?

Please select one of the following

12.6%
35.5%
53.9%
66.2%

Question 2 (of 4)

What was the 12-month prevalence of any comorbid anxiety disorder in adults with ADHD in the US National Comorbidity Survey Replication?

Please select one of the following

13.6%
21.3%
35.4%
47.1%

Question 3 (of 4)

What was the 12-month prevalence of comorbid ADHD in adults with generalised anxiety disorder in the US National Comorbidity Survey Replication?

Please select one of the following

2.8%
11.9%
16.3%
21.2%

Question 4 (of 4)

In the Swedish population-based twin study by Friedrichs and colleagues (n=17,899; age 20–47 years), which ADHD subtype had the highest odds of comorbid generalised anxiety disorder?

Please mark all that apply

Combined type
Hyperactive-impulsive type
Inattentive type

Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Shire has no influence or control over the content of this third party website.

Continue Cancel